POTE18 inhibitors belong to a specialized class of chemical compounds that target the POTE (Prostate, Ovary, Testes, and Embryo) protein family, specifically the POTE18 isoform. This family of proteins, identified for their highly tissue-specific expression patterns, includes POTE18, which exhibits a notable role in cellular processes such as signaling, structure maintenance, and potentially even gene regulation. POTE proteins are characterized by specific amino acid sequences that include ankyrin repeats and spectrin-like domains, suggesting their involvement in cytoskeletal organization and protein-protein interactions. POTE18 inhibitors typically act by interfering with the binding domains of the protein, thereby modulating its natural cellular functions. This inhibition can have a range of effects depending on the biochemical pathways in which POTE18 is involved. It is not uncommon for these inhibitors to exhibit selectivity in their targeting of specific protein motifs, making them particularly interesting from a molecular standpoint.
From a structural perspective, POTE18 inhibitors often feature well-defined molecular frameworks that allow them to bind with high affinity to POTE18's active or regulatory sites. This binding may involve a combination of hydrophobic interactions, hydrogen bonding, and Van der Waals forces that ensure stability and specificity of the inhibitor-protein interaction. In many cases, these inhibitors are designed to exploit the unique structural features of POTE18, thereby preventing unwanted interactions with similar proteins in the POTE family. The development of these inhibitors typically involves detailed structural studies using techniques like X-ray crystallography and computational modeling to understand the precise folding and domains of POTE18. This allows for the fine-tuning of inhibitor properties, such as binding efficiency, conformational flexibility, and the kinetics of the inhibition process, making POTE18 inhibitors a fascinating subject of biochemical research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a potent, non-selective inhibitor of protein kinases, potentially affecting signaling pathways related to POTE18. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $74.00 | 256 | |
Z-VAD-FMK is a pan-caspase inhibitor, potentially influencing apoptosis pathways related to POTE18 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, potentially impacting cell survival and apoptosis pathways related to POTE18. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which may indirectly influence pathways involving POTE18. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is an inhibitor of MEK, potentially affecting MAPK/ERK signaling pathways related to POTE18. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a PI3K inhibitor, potentially affecting cell signaling pathways related to POTE18. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, potentially impacting cell growth and apoptosis pathways related to POTE18. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is a proteasome inhibitor, potentially influencing protein degradation pathways that could be related to POTE18. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin has multiple cellular targets, potentially affecting signaling pathways and apoptosis related to POTE18. | ||||||